Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Aug 7, 2019 · 10-Q · 38 days after period end · 0001171843-19-005225
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Net Income | -$5.32M | -$4.88M | -$5.61M | -$7.91M |
| EPS Diluted | -$0.56 | -$0.28 | -$0.33 | -$0.48 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 7, 2019 · 38 d after period end
